SK
Sanjeev Kumar
Lead Investigators · Cedars-Sinai Medical Center
Credentials: · · ·
History
Present
- 1998–2000
Nephrology
- 1995–1998
Internal Medicine
- 1991–1995
Doctor of Medicine
Research
Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
Kidney International Reports · 2020 · 90 citations
Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
Transplantation · 2022 · 3 citations
Transplantation Direct · 2026
3 papers · 2 as a fellow
2 papers
2 papers
- RN
2 papers
- SM
2 papers
2 papers
1 paper
- AB
1 paper
